Full Text View
Tabular View
No Study Results Posted
Related Studies
COMBINE (Acamprosate/Naltrexone)
This study has been completed.
Study NCT00006206   Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First Received: September 11, 2000   Last Updated: November 27, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcoholism
More general conditions related to this trial
Alcohol-Related Disorders
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
naltrexone (Revia)
acamprosate (Campral)
Additional drug interventions recognized in this trial
Acamprosate
Naltrexone
More general drug interventions related to this trial
Alcohol Deterrents
Central Nervous System Agents
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Lipha Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services